Wafik S. El-Deiry: Great strategic research planning session with scientific and clinical leaders at Legorreta Cancer Center
Wafik S. El-Deiry posted on X:
“Great strategic research planning session with scientific and clinical leaders at Legorreta Cancer Center at Brown University. There is something magical and that is great to see when a senior leadership group works intensively together for many months to shape a future vision at a place like Brown University.
It takes a special group to work cohesively together across disciplines with a common mission and vision. Honored to facilitate the pursuit of research excellence to serve our communities in Rhode Island and beyond. Research and innovation bring hope for better days with less burden from cancer here and elsewhere.”
Source: Wafik S. El-Deiry/X
Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023